NEW YORK (GenomeWeb) – Horizon Discovery today announced it has reached a non-exclusive licensing agreement with the Broad Institute for intellectual property related to the CRISPR-Cas9 gene editing system.

Horizon has gained the rights for the commercial use of the technology for applications such as the development of reagents and tools, as well as the provision of services that use CRISPR. Those services include Horizon's Genassist offering, which encompasses products and services for CRISPR and rAAV gene editing.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.